Back to top

Regentis Biomaterials (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

Austin, Texas, United States, August 14th, 2026, FinanceWire A new Japanese patent allowance follows a recent such US patent grant, strengthens pro...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: